BAD is associated with cellular apoptosis, a process implicated in AD and other neurodegenerative diseases (Obulesu and Lakshmi 2014), and the observed upregulation of BAD protein expression in AD brains (Kitamura et al. 1998) suggest its potential as a therapeutic target. The gene discussed is BAD; the disease is neurodegenerative disease.